The imaging system uses multiple cameras and an array of LEDs, both near-infrared and white light ones, to differentiate between normal tissue and tissue that has a concentration of the dye present. Near-infrared light is used to excite the dye and to produce fluorescence that the cameras can see. White light is used to capture the field of view in order to overlay the location of the tumor on top of it.
At RSNA 2016 in Chicago, SurgVision, a Dutch firm, was showing off its intra-surgical molecular probe fluorescence imaging system designed for excising hard to spot tumors. The system relies on novel dyes attached to tumor-seeking antibodies and a multi-spectral fluorescence imaging camera to spot the dye within tissue.
During the development of tracers, apart from the SurgVision platform technology, SurgVision also provides customization services to help you apply the technology to reach your target, and advice and support to help you achieve confidence in your results.